Friday, 12 August 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 12 August 2022
Ascott 3
Ascott 3
Could Moderna be the next Apple?

Moderna's boss says the company's Covid vaccine, Spikevax, is just like Apple's mega product, the iPhone. Find out why and what it means for the company's future.

Why Pfizer staff deserve more pay
ICYMI: The stories that topped this week
TODAY Your Week in Five Minutes
You won't guess who's leaving
'Long stay' staffers head for the exit creating new jobs headache
TODAY
Clock ticks for pharma marketers
Pressure on to create fast content for time-poor HCPs
TODAY
HPG
HPG
New listing off like a rocket
Expectations were high but the uptake even higher
11 August
Pfizer workers walk out over pay
Workers take industrial action over insufficient wages offer
10 August
Roche set to drive booming market
New drug to triple existing market with multi-billion dollar growth
10 August
Career climbing on maternity leave
AbbVie Mum earns double mat leave promotions
10 August
Ampco 2
Ampco 2
Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (15)

Clinical & Medical, R&D (13)

Regulatory, Pharmacovigilance & QA (6)

Devices (1)

Other (17)

Covid antiviral turf war kicks off
Availability issues spark a bitter war of words
TODAY
New tools to boost patient data
New partnership boosts ability to measure outcomes
TODAY
CSL unveils new global branding
New names and slogan bring CSL 'family' together
11 August
New lab bridges 'valley of death'
Boosting production of vaccines and medicines onshore
11 August
Local outfit nabs Big Pharma deal
New agreement aimed at enhancing antibody drug conjugates
11 August
Unapproved vax ready for rollout
Government wheels out rarely used emergency use powers
11 August
Caught snoring on Teams calls
Outed for being dog tired and sleeping on the job
11 August
Local pharma lands fat US deal
Ten year investment pays off with new focus on growth portfolios
10 August
Novel drug to shake up big market
Discovery of potential game changer in diabetes treatment
10 August
Who's still sitting on a gold mine?
What patent cliff? Originator blockbuster shrugs off rivals
10 August
Pfizer caught in bitter crossfire
Regulator under attack by Aussie company but hits back
9 August
New threat to trigger mass exodus
So-called 'office creep' could see a quarter of the workforce quit
9 August
Hardest hit drugs in US price reform
Speculation over which big drugs are facing a price squeeze
9 August
Who scored double workplace win?
Not only a Best Workplace but also Champions of Change
9 August
pif audio
pif audio
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.